AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 284: H1460-H1467, 2003. First published December 12, 2002; doi:10.1152/ajpheart.00700.2002
0363-6135/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/4/H1460    most recent
00700.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maurel, A.
Right arrow Articles by Francés, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maurel, A.
Right arrow Articles by Francés, B.
Vol. 284, Issue 4, H1460-H1467, April 2003

Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats

Agnès Maurel, Carole Hernandez, Oksana Kunduzova, Guy Bompart, Claudie Cambon, Angelo Parini, and Bernard Francés

Unité 388, Institut National de la Santé et de la Recherche Médicale, Institut Louis Bugnard, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse cedex 04, France


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Oxidative stress is one of the factors involved in age-related impairment of cardiac function. In the present study, we investigated the role of the catecholamine-degrading enzyme monoamine oxidase (MAO) in H2O2 production in the hearts of young, adult, and old rats. MAO-dependent H2O2 production, measured by a chemiluminescence-based assay, increased with age, reaching the maximum in 24-mo-old rats (7.5-fold increase vs. 1-mo-old rats). The following observations indicate that the age-dependent increase in H2O2 generation was fully related to the MAO-A isoform: 1) at all the ages tested, chemiluminescence production was inhibited by the MAO-A inhibitor clorgyline but not by the MAO-B inhibitor RO-19 6327; 2) enzyme assay, Western blot, and semiquantitative RT-PCR analysis showed an age-dependent increase in cardiac MAO-A activity, immunodetection, and mRNA expression, respectively; and 3) the MAO-B isoform was undetectable by enzyme assay and Western blot analysis. These results suggest that MAO-A could be a major source of H2O2 in the aging heart.

monoamine oxidases; oxidative stress


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

REACTIVE OXYGEN SPECIES (ROS) occupy a prominent position in aging processes (45, 57). These substances may participate in cell aging by different mechanisms, including protein and lipid oxidation and DNA damage (33, 46, 57). ROS can be generated by multiple sources, such as xanthine oxidase (21), NADPH oxidase (5), and the mitochondrial respiratory chain (19, 26, 27). In normal situations, the physiological intracellular redox state is maintained by the equilibrium between ROS production by the different sources and inactivation by antioxidant systems (51). The alteration of such an equilibrium leads to an increase in intracellular ROS concentration and to the subsequent oxidative stress. In aging, the increase in intracellular ROS and the oxidative stress-dependent decline of cell functions have been related, in part, to impairment of the mitochondrial respiratory chain (2, 26-28). The mitochondrial enzymes monoamine oxidase (MAO) A and B, which play a major role in the oxidative deamination of biogenic [catecholamines and serotonin (5-hydroxytryptamine, 5-HT)] and exogenous amines (i.e., tyramine) (56), are a source of hydrogen peroxide (H2O2). Convergent evidences suggest their involvement in aging processes (9, 47). Indeed, the increase in MAO activity has been associated to the detrimental structural and functional processes of aging in some brain regions (18, 29, 40-42, 47).

Recently, we have shown that H2O2 generated by MAOs during substrate degradation is involved in cell proliferation (52, 53) and apoptosis (P. Bianchi, M. H. Séguélas, A. Parini, and C. Cambon, personal communications), two events associated with aging (31, 39, 54, 55).

In the aging heart, the increase in ROS production has been considered as one of the factors involved in myocyte apoptosis and reactive hypertrophy, two processes contributing to the development of cardiac failure (3, 4, 34-36, 43). Moreover, the impairment of cardiac metabolic and functional tolerance toward oxidative stress and a decrease in some cardiac scavenger enzymes have been implicated in the process of cardiac aging (1). As reported for other tissues, the age-dependent oxidative stress in the heart is related, in part, to mitochondrial dysfunction (38, 43). Indeed, these organelles have increasing capacities to produce H2O2 and generate lipid peroxidation in the aging heart (32). MAOs are highly expressed in the rat heart (10, 43). Enzyme assay using specific MAO-A and MAO-B substrates showed a predominant expression of the MAO-A isoenzyme in the rat heart. However, these studies supplied intriguing results. Indeed, the degradation of the MAO-B substrate beta -phenylethylamine (beta -PEA) was prevented by the MAO-A inhibitor RO-41 1049 and poorly affected by the MAO-B inhibitor RO-19 6327 (49). At present, it is still unknown whether this unusual pattern of beta -PEA degradation is related to the expression of atypical forms of MAOs or to particular conformational states of the enzymes.

Although an increase in cardiac MAO activity with age has been reported (10, 30), the involvement of MAOs in H2O2 production in the aging heart and the relative role of each isoenzyme have not been investigated.

In the present report, we studied H2O2 production by MAOs in the hearts of young (1 mo), adult (3 and 6 mo), and old (24 mo) rats. Our results show that aging induces a strong increase in H2O2 production by MAOs. By combining chemiluminescence (CL) assay, enzyme activity, Western blot, and semiquantitative RT-PCR analysis, we demonstrated that the age-dependent raise in H2O2 production by MAOs is fully related to the increase in the expression of the MAO-A form. This isoenzyme maintains the ability to oxidize the MAO-B substrate beta -PEA and displays molecular properties typical of the classical MAO-A form.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Materials. 5-[14C]HT (specific activity = 52.3 Ci/mol) and beta -[14C]PEA (specific activity = 52 Ci/mol) were obtained from DuPont NEN (Life Science Products; Boston, MA). Tyramine, pargyline, clorgyline, RO-41 1049, and lazabemide (RO-19 6327) were purchased from Sigma-Aldrich (St. Louis, MO). Rabbit beta -ATPase antibody was a generous gift from Dr. Lunardi (Biochemical Laboratory; Grenoble, France).

Crude total membrane fraction preparation. Hearts of male Sprague-Dawley rats (Harlan; Gannat, France) at the ages of 1, 3, 6, and 24 mo were washed in ice-cold phosphate buffer (50 mM, pH 7.4) supplemented with protease inhibitors (0.1 mM PMSF, 10 µg/ml bacitracin, and 2 µg/ml soybean trypsin inhibitor), hereafter referred to as phosphate buffer, and ground in a Turrax homogenizer (IKA Labortechnik; Staufen, Germany). After 10 additional passes in a Dounce homogenizer, the homogenate was centrifuged for 10 min at 1,800 g and 4°C. The resulting pellet was discarded, whereas the supernatant was homogenized for a second time in a Dounce homogenizer and centrifuged for 20 min at 16,000 g and 4°C. Finally, the supernatant was eliminated, and the pellet was resuspended in ice-cold phosphate buffer to obtain a concentration of 1 mg/ml protein and stored at -80°C.

MAO activity. Crude total membrane fractions (20-40 µg) were incubated at 37°C for 20 min in a final volume of 50 µl phosphate buffer with increasing concentrations of 5-[14C]HT (0-500 µM) or beta -[14C]PEA (0-10 µM) to measure MAO-A and MAO-B activities, respectively. The irreversible MAO inhibitor pargyline (10 µM) was used to defined nonspecific MAO-A or MAO-B activity. After 20 min, the reaction was ended by adding 100 µl of 4 N HCl at 4°C. The deaminated products were the extracted by adding 1 ml toluene-ethyl acetate (vol/vol) and vigorous mixing (92% efficiency). Finally, 750 µl of the organic phase were counted in a liquid scintillation spectrophotometer with 97% of performance (Packard 1900 TR). MAO activity was expressed as picomoles of oxidized substrate during 1-min incubation per milligram of protein.

MAO steady-state kinetic parameters were evaluated using a nonlinear least-square curve-fitting procedure (GraphPad Prism; San Diego, CA).

H2O2 production assay. As previously reported, the luminol-amplified CL assay is a sensitive procedure to measure the specific contributions of MAO-A and MAO-B to H2O2 production (37).

H2O2 production was measured by CL assay on heart homogenates (100 µg protein) in the presence of luminol (10 µM) and horseradish peroxidase (0.1 U/ml) by using a thermostatically (37°C) controlled luminometer (Bio-Orbit 1251; Turku, Finland). The generation of CL triggered with tyramine (20 µM), a common MAO substrate, was continuously monitored during 85 min, and the area under the curve (total CL emission) was analyzed by the Bio-Orbit MultiUse program. Inhibition of luminescence by selective MAO-A inhibitor (10 µM clorgyline) or MAO-B inhibitor (10 µM RO-19 6327) was measured to control the specificity of H2O2 production.

Immunoblots. Crude total membrane fractions (30 µg) were solubilized in 4× Laemmli sample buffer (187 mM Tris · HCl, 2% SDS, 20% glycerol, 0.7 M beta -mercaptoethanol, and 0.025% bromophenol blue; pH 6.8) and loaded per well onto 8% SDS-PAGE gels (migration buffer: 124 mM Tris · HCl, 0.5% SDS, and 0.96 glycine; pH 8.3). Electrophoretically resolved proteins were transferred to polyvinylidiene difluoride membranes (NEN Life Science Products) by semidry electroblotting (Trans-blot SD, Bio-Rad Laboratories; Richmond, VA). Blots were blocked overnight at 4°C with 5% milk in wash buffer [PBS (pH 7.40)-0.1% Tween 20], washed, and incubated for 1 h at room temperature with rabbit anti-MAO-A/MAO-B polyclonal antiserum. The polyclonal antiserum was obtained from immunized rabbits with the peptide TNGGQERKFVGGSGQ, corresponding to amino acids 210-225 in MAO-A and 202-217 in MAO-B. The specificity of the antibody was previously determined by peptide competition in heterologous expression systems and various tissues (37). After being washed, blots were incubated with peroxidase-labeled anti-rabbit IgG for 30 min. Bound antibodies were detected using enhanced CL (ECL kit, Amersham Pharmacia Biotech; Buckinghamshire, UK) and exposure to Hyperfilm MR (Amersham Pharmacia Biotech). Immunoblot analysis with the rabbit anti-beta -ATPase polyclonal antiserum was used as an internal mitochondrial standard to quantify proteins.

Semiquantitative RT-PCR. Total RNA were extracted from frozen powdered tissues (100-200 mg) using the acid guanidium thiocyanate-phenol-chloroform method as described by Chomczynski and Sacchi (13).

First-strand cDNA was synthesized from 1 µg total RNA by RT for 60 min at 42°C in a final volume of 20 µl RT buffer with 100 units SuperScript II, 0.25 µg oligo(dT)12-18, 0.5 mM dNTPs, 5 mM DTT, and 32 units RNase inhibitor (Invitrogen; Paisley, UK).

Five microliters of denaturated (94°C for 2.5 min) first-strand cDNA were then used to amplify MAO-A, MAO-B, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) fragments by PCR. Fifty microliters of the reaction mix containing PCR buffer with 1.5 mM MgCl2, 0.2 mM dNTPs, 60 nM primer couples, 2 units Taq polymerase (Invitrogen), and the RT product were amplified with a DNA thermal cycler (TRIO, Thermoblock Biometra; Göttingen, Germany). To evaluate PCR products comparatively, we amplified the MAO and GAPDH products for 30 and 20 cycles at the same time, respectively. A cycle was composed of a denaturation step at 95°C for 1 min, a primer annealing step at 56°C for 1 min, and an extension step at 72°C for 2 min. The final extension step was prolonged to 10 min. The absence of contaminants was routinely checked by RT-PCR assays of negative control samples in which the SuperScript II was omitted.

Primers used. Primers for MAO-A were defined by bases 1,537-1,556 [5'-GTGGCTCTTCTCTGCTTTGT-3' (forward)] and 2,037-2,016 [5'-AGTGCCAAGGGTAGTGTGTATCA-3' (reverse)]. Primers for MAO-B were defined by bases 1,415-1,434 [5'-TCCCAGCAAGACCCATTACC-3' (forward)] and 2,252-2,229 [5'-TGACAAAGACAAGACTCCCATTCTC-3' (reverse)] (23). Primers for GAPDH were defined by bases 510-529 [5'-AATGCATCCTGCACCACCAA-3' (forward)] and 980-960 [5'-GTCATTGAGAGCAATGCCAGC-3' (reverse)] (20). The expected sizes of the amplification products were 500 and 837 bp for MAO-A and MAO-B, respectively, and 470 bp for GAPDH.

Protein determination. Protein concentration was performed by using a modified Lowry procedure (DC protein assay, Bio-Rad Laboratories) using gamma -globulin as a standard.

Statistical analysis. Values are expressed as means ± SE. The statistical significance of differences among the experimental groups was evaluated by one-way ANOVA, followed by a Newman-Keuls post test (GraphPad Prism).


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

H2O2 production in aging hearts. To determine the involvement of MAOs in H2O2 production in the aging heart, we used a luminol-based CL assay. We have previously shown that the use of the MAO-A/MAO-B substrate tyramine in this technique allows evaluation of H2O2 production by each MAO isoenzyme (37). As shown in Fig. 1A, experiments performed in 3-mo-old rats showed that incubation of heart homogenates with tyramine (20 µM) led to a time-dependent increase in CL that was inhibited by the MAO-A inhibitor clorgyline (10 µM) but not by the MAO-B inhibitor RO-19 6327 (10 µM). Tyramine-dependent CL generation increased with age, reaching the maximum in 24-mo-old rats (7.5-fold increase compared with 1-mo-old rats). At all the ages tested, CL production was inhibited by clorgyline and unaffected by RO-19 6327 (Fig. 1B). These results show an increase in H2O2 production by MAOs and suggest the predominant role of the MAO-A isoenzyme in this effect.


View larger version (25K):
[in this window]
[in a new window]
  		Fig. 1.   Monoamine oxidase (MAO)-dependent H2O2 production in heart homogenates. A: generation of chemiluminescence monitored for 85 min after 20 µM tyramine addition to 3-mo-old rat heart homogenates, as described in MATERIALS AND METHODS. Heart homogenates were preincubated 20 min with 10 µM clorgyline or 10 µM RO-19 6327 before tyramine addition. The plot is representative of four separate experiments, and results are expressed in millivolts. B: H2O2 production measured in 1-, 3-, 6-, and 24-mo-old rat heart homogenates (open bars) with 10 µM clorgyline (solid bars) or 10 µM RO-19 6327 (hatched bars). The histograms represent the means ± SE of four separated experiments and are expressed as a percentage of control CL at 1 mo. *P < 0.05 vs. 1 mo.

Characterization of MAOs in aging hearts. Previous studies showed an unusual pattern of substrate selectivity of rat cardiac MAOs, suggesting the potential expression of atypical MAOs in the heart (49). To identify the MAOs responsible for H2O2 production during heart development and aging, we characterized rat cardiac MAOs by combining enzyme assays, Western blot, and semiquantitative RT-PCR analysis.

Enzyme assays were performed using 5-[14C]HT and beta -[14C]PEA as selective substrates for MAO-A and MAO-B, respectively. As shown in Fig. 2, the equilibrium parameters of 5-[14C]HT oxidation showed an age-dependent increase in MAO-A activity. The rate of 5-[14C]HT oxidative deamination was 32-fold higher in 24-mo-old rats than in 1-mo-old rats. We also observed a weak but significant increase in the Km of the 5-[14C]HT degradation rate, suggesting a possible age-related conformational change of heart MAO-A.


View larger version (25K):
[in this window]
[in a new window]
  		Fig. 2.   MAO-A activity in the aging heart. The specific MAO-A activity was assessed by oxidation of the MAO-A substrate 5-[14C]hydroxytryptamine (5-[14C]HT; 0-500 µM) in the absence or presence of the irreversible MAO inhibitor pargyline (10 µM), as described in MATERIALS AND METHODS. Data show representative saturation curves of 5-[14C]HT oxidative deamination in heart homogenates at the ages of 1, 3, 6 and 24 mo. Maximal velocity (Vmax; in pmol · min-1 · mg protein-1) and Km (µM) values are means ± SE; n = 4 animals. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. 1 mo; §P < 0.05 and §§§P < 0.001 vs. 3 mo; #P < 0.05 and ##P < 0.01 vs. 6 mo.

As observed for 5-[14C]HT oxidation, beta -[14C]PEA degradation increased with age (Fig. 3A). However, beta -PEA oxidation was a linear function and was inhibited by the MAO-B inhibitor RO-19 6327 with an affinity (IC50 = 286 ± 1.3 µM) lower than that reported for MAO-B (7). In contrast, at all the ages tested, beta -PEA degradation was inhibited with high affinity by the MAO-A inhibitors clorgyline (IC50 = 14.5 ± 1.1 µM) and RO-41 1049 (IC50 = 33 ± 1.2 µM) (Fig. 3B). These results indicate that, at all the ages tested, MAO-B cannot be quantified using beta -PEA and that the increase in beta -PEA oxidation with aging is unrelated to a modification of MAO-B expression. This is further demonstrated by the lack of detection of MAO-B protein by Western blot (Fig. 3C). The selective age-dependent modification of MAO-A expression and the lack of MAO-B regulation with age were further confirmed by Western blot and semiquantitative RT-PCR analysis. Indeed, Western blots (Fig. 4) showed an immunoreactive 60-kDa band corresponding to MAO-A in crude total membrane fractions of 1-mo-old rats. The quantification of MAO-A protein, expressed as the ratio of the optical densities relative to MAO-A and mitochondrial beta -ATPase bands, showed that MAO-A increased progressively with age, reaching the maximum in 24-mo-old rats (4-fold at 6 mo and 6-fold at 24 mo vs. 1 mo). In contrast, the 55-kDa immunoreactive band corresponding to MAO-B was undetectable at all the ages tested. The results of Western blot analysis were confirmed by semiquantitative RT-PCR analysis. GADPH, as previously reported (48), was used as a reference to normalize the changes in expression of MAO-A and MAO-B genes. As shown in Fig. 5, the intensity of RT-PCR products corresponding to MAO-A significantly increased with age, being 2.9-fold and 4-fold more intense in 6- and 24-mo-old rats compared with 1-mo-old rats, respectively. Semiquantitative RT-PCR allowed the amplification of a cDNA fragment corresponding to MAO-B. The identity of this amplification product was confirmed by DNA sequencing. The intensity of this RT-PCR product was much lower than that corresponding to MAO-A and was not modified by aging.


View larger version (23K):
[in this window]
[in a new window]
  		Fig. 3.   MAO-B activity in the aging heart. A: MAO-B activity assessed by oxidation of beta -[14C]phenylethylamine (beta -[14C]PEA; 0-10 µM) in the absence or presence of the irreversible MAO inhibitor pargyline (10 µM), as described in MATERIALS AND METHODS. R2 values show that beta -PEA oxidative deamination was a linear function of beta -PEA concentration. The plot is representative of four independent experiments. B: data showing the inhibition curves of 10 µM beta -[14C]PEA oxidative deamination by clorgyline (black-down-triangle ), RO-41 1049 (black-triangle), or RO-19 6327 () in heart crude total membrane fractions of 3 mo old rats. The plot is representative of four independent experiments. C: heart and liver crude total membrane fractions of 3-mo-old rats immunoblotted with the rabbit polyclonal anti-MAO-A/MAO-B antiserum, as described in MATERIALS AND METHODS. Blot is representative of four independent experiments.



View larger version (27K):
[in this window]
[in a new window]
  		Fig. 4.   MAO protein expression in aging heart Western blots were performed on the rat heart crude total membrane fractions of 1-, 3-, 6-, and 24-mo-old rats. Thirty micrograms of crude extract were loaded onto gels for electrophoresis and processed as described in MATERIALS AND METHODS. The liver sample was used as a control to locate MAO-A and MAO-B bands at 60 and 55 kDa, respectively. The histograms represent the ratio of optical densities corresponding to cardiac MAO-A and beta -ATPase bands, expressed as means ± SE; n = 4 animals. *P < 0.05 and ***P < 0.001 vs. 1 mo.



View larger version (24K):
[in this window]
[in a new window]
  		Fig. 5.   MAO mRNA expression in the aging heart. Semiquantitative RT-PCR was performed, as described in MATERIALS AND METHODS, from isolated total RNA of rat hearts at the age of 1, 3, 6, and 24 mo. The relative expression of MAO mRNA was determined as the ratio of optical densities of MAO (MAO-A, open bars; MAO-B, solid bars) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) bands in the heart. The histograms represent the means ± SE of four separate experiments. *P < 0.05 and ***P < 0.001 vs. 1 mo; §§P < 0.01 vs. 3 mo.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In the present study, we show that MAO-A is the major source of MAO-dependent H2O2 production in the rat heart. We also demonstrated that cardiac H2O2 generation by MAO-A strongly increases with age. In contrast, we found that MAO-B does not contribute to cardiac H2O2 generation in young, adult, and old rats.

Oxidative stress plays a pivotal role in the development of cardiac diseases (16, 43). One of the most classical examples demonstrating the impact of ROS in cardiac injury is postischemia-reperfusion syndrome. This situation occurs frequently, as seen by the large number of patients treated by coronary angioplasty and heart transplantation. In such conditions, ROS may participate in the apoptotic and necrotic cell death, leading to the irreversible loss of cardiac tissue and, in many cases, to heart failure (25).

In addition to postischemia-reperfusion syndrome, H2O2 generated by MAOs may also participate in cardiomyocyte dysfunctions associated with left ventricular hypertrophy and/or dilatation (11, 26, 35, 43). This modification of normal left ventricular structure and function, which is typical of different pathologies whose frequency increase with age (i.e., hypertension, myocardial infarction, and valvulopathies), is related to ventricular hemodynamic overload and reactive cardiac remodeling. Several studies have shown that ROS play a critical role in cardiomyocyte hypertrophy and apoptosis, two processes leading to left ventricular remodeling and cardiac failure (11, 26, 35, 43). The increase in cardiac ROS in ventricular hypertrophy and dilatation has been related, in part, to the decrease in the expression of the antioxidant enzyme superoxide dismutase (1, 6, 15, 44). However, it has been suggested that a concomitant decrease in the antioxidant systems and an increase in ROS production may be necessary to induce oxidative stress and cell damage in cardiomyocytes. At present, the intracellular sources responsible for the increase in ROS production in ventricular hypertrophy and heart failure have not been clearly identified. Despite the therapeutical properties of the xanthine oxidase inhibitor allopurinol in the prevention of ventricular hypertrophy and dilatation (12, 17), the low expression of this enzyme in cardiomyocytes makes questionable its role in the promotion of oxidative stress-dependent cell damage. The cardiac homologs of phagocyte NADPH oxidase subunits have been recently described in cardiac myocytes (22). In phagocytes, NADPH oxidase is responsible for a large production of O<UP><SUB>2</SUB><SUP>−</SUP></UP>· and H2O2 by the means of superoxide dismutase. Converging evidence supports the potential role of cardiac NADPH oxidase in cardiomyocyte hypertrophy and apoptosis. However, additional studies are necessary to define the functional properties of this enzyme in the heart and its involvement in physiological and pathological situations. Although both xanthine and NADPH oxidases are potentially relevant in term of ROS generation in the heart, their role in cardiac dysfunction associated with aging is far from being evident. Indeed, at present, there is no strong evidence showing an age-dependent increase in cardiac xanthine and NADPH oxidase activities.

Cardiomyocytes are extremely rich in mitochondria, and these organelles are one of the major sources of ROS. In different situations, the impairment of the mitochondrial respiratory chain leads to leakage of electrons to oxygen to form O<UP><SUB>2</SUB><SUP>−</SUP></UP>·. In different animal models of cardiac hypertrophy or dilatation, the increase in ROS production is related to mitochondrial dysfunction (32, 50). On the other hand, a decline in mitochondrial function leading to enhanced oxidant production has been described in different aging processes, not only in the heart but also in various organs (38). The mechanisms responsible for mitochondrial decay have not been entirely identified. Recent studies performed in isolated mitochondria have suggested that H2O2 generated by MAOs during substrate degradation may be involved in the impairment of the mitochondrial respiratory chain (14). According to these results, we have recently shown that, in epithelial renal cells, H2O2 production by MAOs is responsible for cytochrome c release by mitochondria, leading to the activation of the proapoptotic cascade (P. Bianchi, M. H. Séguélas, A. Parini, and C. Cambon, personal communications). With the use of a rat model of renal ischemia-reperfusion, we confirmed the essential role of H2O2 generated by MAOs in postreperfusion tissue injury (24). Indeed, we showed that in the kidney, MAO inhibition dramatically prevented oxidative stress, activation of the proapoptotic cascade, and cell apoptosis/necrosis occurring after reperfusion. Experiments in progress in our laboratory also strongly support the role of MAOs in postischemia-reperfusion tissue injury in the heart. The demonstration that, in the heart, H2O2 generation by MAOs is dramatically increased in old rats proposes these enzymes as one of the major sources of ROS involved in age-related mitochondrial dysfunction and oxidative stress.

In addition to the demonstration that MAOs may play a role in cardiac dysfunctions associated with aging, our results supply new insights on the characteristics of MAOs expressed in the heart and in the mechanisms of their regulation. Enzyme assay and Western blot analysis did not reveal the expression of functional MAO-B protein in the rat heart. According to previous results (49), we showed that degradation of the MAO-B substrate beta -PEA is provided by MAO-A and that this peculiarity is maintained during heart development and aging. The unusual substrate specificity of MAO-A suggested the expression of an atypical form of the MAO-A isoenzyme in the rat heart (49). In our study, Western blot analysis of heart crude total membrane fractions with the polyclonal anti-MAO-A/MAO-B antiserum revealed a single band with an apparent molecular weight corresponding to that of "classic" MAO-A. In addition, semiquantitative RT-PCR analysis with primers covering the entire coding region of MAO-A cDNA did not reveal amplification products different from those of MAO-A (T. Guimaraes, C. Vindic, and A. Parini, personal communications). These results suggest that the unusual substrate selectivity of rat cardiac MAO-A may be related to a particular conformational state of MAO-A rather than to the expression of an additional form of the isoenzyme.

We have previously shown that, in the rat kidney, the change in MAO-A activity during development or steroid treatment was more likely related to modification of substrate accessibility rather than to a difference in protein expression (8). Our results suggest that the mechanisms of development and age-dependent regulation in the heart differ from those observed in the kidney. Indeed, Western blot analysis showed an age-dependent increase in MAO-A protein concomitant to an augmentation in the intensity of MAO-A cDNA fragments amplified and quantified by semiquantitative RT-PCR analysis. Therefore, in the heart, the increase in MAO-A activity seems to be related to a modification of the transcriptional rate of the MAO-A gene and/or to a higher stability of the corresponding mRNA. It is noteworthy that, although we have not been able to show the expression of MAO-B protein in the heart, we could detect a weak RT-PCR amplification product corresponding to MAO-B. At present, we cannot define whether these results reflect a very low expression of MAO-B protein in the heart. Nevertheless, it is clear that the intensity of the MAO-B RT-PCR products did not change with age, making unlikely the potential role of the MAO-B isoenzyme in the increase of MAO-dependent H2O2 generation in the heart.

In conclusion, the demonstration that MAO-A-dependent H2O2 production strongly increases in the senescent heart proposes this enzyme as one of the major factors involved in cardiac oxidative stress during aging. Additional experiments are needed to define the functional role of MAO-A in physiological and pathological situations. It is conceivable that the inhibition of MAOs may represent a therapeutical approach to prevent cardiac hypertrophy and dilatation, two diseases associated with aging and induced, at least in part, by oxidative stress.


    FOOTNOTES

Address for reprint requests and other correspondence: A. Parini, INSERM U388, Institut Louis Bugnard, CHU Rangueil, Bât. L3 1, Ave. Jean Poulhès, 31403 Toulouse cedex 4, France (E-mail: parini{at}toulouse.inserm.fr).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

10.1152/ajpheart.00700.2002

Received 4 October 2002; accepted in final form 5 December 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Abete, P, Napoli C, Santoro G, Ferrara N, Tritto I, Chiariello M, Rengo F, and Ambrosio G. Age-related decrease in cardiac tolerance to oxidative stress. J Mol Cell Cardiol 31: 227-236, 1999[Web of Science][Medline].

2.   Ames, BN, Shigenaga MK, and Hagen TM. Mitochondrial decay in aging. Biochim Biophys Acta 1271: 165-170, 1995[Medline].

3.   Anversa, P, Hiler B, Ricci R, Guideri G, and Olivetti G. Myocyte cell loss and myocyte hypertrophy in the aging rat heart. J Am Coll Cardiol 8: 1441-1448, 1986[Abstract].

4.   Anversa, P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, and Capasso JM. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 67: 871-885, 1990[Abstract/Free Full Text].

5.   Babior, BM. NADPH oxidase: an update. Blood 93: 1464-1476, 1999[Free Full Text].

6.   Baumer, AT, Flesch M, Wang X, Shen Q, Feuerstein GZ, and Bohm M. Antioxidative enzymes in human hearts with idiopathic dilated cardiomyopathy. J Mol Cell Cardiol 32: 121-130, 2000[Web of Science][Medline].

7.   Beer, HF, Rossetti I, Frey LD, Hasler PH, and Schubiger PA. 123I-labeling and evaluation of Ro 43-0463, a SPET tracer for MAO-B imaging. Nucl Med Biol 22: 929-936, 1995[Web of Science][Medline].

8.   Bompart, G, Copin N, Djouadi F, Bastin J, Ordener C, and Parini A. Monoamine oxidase in developing rat renal cortex: effect of dexamethasone treatment. Eur J Pharmacol 415: 19-26, 2001[Web of Science][Medline].

9.   Cadenas, E, and Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29: 222-230, 2000[Web of Science][Medline].

10.   Cao Danh, H, Strolin Benedetti M, Dostert P, and Mousset A. Age-related changes in benzylamine oxidase activity in rat tissues. J Pharm Pharmacol 36: 592-596, 1984[Web of Science][Medline].

11.   Capasso, JM, Palackal T, Olivetti G, and Anversa P. Severe myocardial dysfunction induced by ventricular remodeling in aging rat hearts. Am J Physiol Heart Circ Physiol 259: H1086-H1096, 1990[Abstract/Free Full Text].

12.   Cappola, TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E, and Hare JM. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104: 2407-2411, 2001[Abstract/Free Full Text].

13.   Chomczynski, P, and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987[Web of Science][Medline].

14.   Cohen, G, Farooqui R, and Kesler N. Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc Natl Acad Sci USA 94: 4890-4894, 1997[Abstract/Free Full Text].

15.   Dhalla, AK, and Singal PK. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am J Physiol Heart Circ Physiol 266: H1280-H1285, 1994[Abstract/Free Full Text].

16.   Dhalla, NS, Temsah RM, and Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 18: 655-673, 2000[Web of Science][Medline].

17.   Ekelund, UE, Harrison RW, Shokek O, Thakkar RN, Tunin RS, Senzaki H, Kass DA, Marban E, and Hare JM. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res 85: 437-445, 1999[Abstract/Free Full Text].

18.   Fowler, JS, Volkow ND, Wang GJ, Logan J, Pappas N, Shea C, and MacGregor R. Age-related increases in brain monoamine oxidase B in living healthy human subjects. Neurobiol Aging 18: 431-435, 1997[Web of Science][Medline].

19.   Giulivi, C, Boveris A, and Cadenas E. Hydroxyl radical generation during mitochondrial electron transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial DNA. Arch Biochem Biophys 316: 909-916, 1995[Web of Science][Medline].

20.   Goppelt-Struebe, M, Stroebel M, and Hoppe J. Regulation of platelet-derived growth factor isoform-mediated expression of prostaglandin G/H synthase in mesangial cells. Kidney Int 50: 71-78, 1996[Web of Science][Medline].

21.   Granger, DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 255: H1269-H1275, 1988[Abstract/Free Full Text].

22.   Griendling, KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000[Abstract/Free Full Text].

23.   Ito, A, Kuwahara T, Inadome S, and Sagara Y. Molecular cloning of a cDNA for rat liver monoamine oxidase B. Biochem Biophys Res Commun 157: 970-976, 1988[Web of Science][Medline].

24.   Kunduzova, OR, Bianchi P, Pizzinat N, Escourrou G, Seguelas MH, Parini A, and Cambon C. Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J 16: 1129-1131, 2002[Abstract/Free Full Text].

25.   Leichtweis, SB, Leeuwenburgh C, Chandwaney R, Parmelee DJ, and Ji LL. Ischaemia-reperfusion induced alterations of mitochondrial function in hypertrophied rat heart. Acta Physiol Scand 156: 51-60, 1996[Web of Science][Medline].

26.   Lenaz, G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 52: 159-164, 2001[Web of Science][Medline].

27.   Lenaz, G, Bovina C, D'Aurelio M, Fato R, Formiggini G, Genova ML, Giuliano G, Pich MM, Paolucci U, Castelli GP, and Ventura B. Role of mitochondria in oxidative stress and aging. Ann NY Acad Sci 959: 199-213, 2002[Web of Science][Medline].

28.   Liu, Y, Fiskum G, and Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem 80: 780-787, 2002[Web of Science][Medline].

29.   Mahy, N, Andres N, Andrade C, and Saura J. Age-related changes of MAO-A and -B distribution in human and mouse brain. Neurobiology (Bp) 8: 47-54, 2000.

30.   Meco, M, Bonifati V, Collier WL, Ramacci MT, and Amenta F. Enzyme histochemistry of monoamine oxidase in the heart of aged rats. Mech Ageing Dev 38: 145-155, 1987[Web of Science][Medline].

31.   Monti, D, Troiano L, Tropea F, Grassilli E, Cossarizza A, Barozzi D, Pelloni MC, Tamassia MG, Bellomo G, and Franceschi C. Apoptosis-programmed cell death: a role in the aging process? Am J Clin Nutr 55: 1208S-1214S, 1992[Abstract/Free Full Text].

32.   Muscari, C, Caldarera CM, and Guarnieri C. Age-dependent production of mitochondrial hydrogen peroxide, lipid peroxides and fluorescent pigments in the rat heart. Basic Res Cardiol 85: 172-178, 1990[Web of Science][Medline].

33.   Mylonas, C, and Kouretas D. Lipid peroxidation and tissue damage. In Vivo 13: 295-309, 1999[Web of Science][Medline].

34.   Olivetti, G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, and Anversa P. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 26: 1068-1079, 1995[Abstract].

35.   Olivetti, G, Melissari M, Capasso JM, and Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 68: 1560-1568, 1991[Abstract/Free Full Text].

36.   Pimentel, DR, Amin JK, Xiao L, Miller T, Viereck J, Oliver-Krasinski J, Baliga R, Wang J, Siwik DA, Singh K, Pagano P, Colucci WS, and Sawyer DB. Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res 89: 453-460, 2001[Abstract/Free Full Text].

37.   Pizzinat, N, Copin N, Vindis C, Parini A, and Cambon C. Reactive oxygen species production by monoamine oxidases in intact cells. Naunyn Schmiedebergs Arch Pharmacol 359: 428-431, 1999[Web of Science][Medline].

38.   Pollack, M, Phaneuf S, Dirks A, and Leeuwenburgh C. The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann NY Acad Sci 959: 93-107, 2002[Web of Science][Medline].

39.   Sauer, H, Wartenberg M, and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11: 173-186, 2001[Web of Science][Medline].

40.   Saura, J, Andres N, Andrade C, Ojuel J, Eriksson K, and Mahy N. Biphasic and region-specific MAO-B response to aging in normal human brain. Neurobiol Aging 18: 497-507, 1997[Web of Science][Medline].

41.   Saura, J, Richards JG, and Mahy N. Age-related changes on MAO in Bl/C57 mouse tissues: a quantitative radioautographic study. J Neural Transm, Suppl 41: 89-94, 1994[Medline].

42.   Saura, J, Richards JG, and Mahy N. Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs. Neurobiol Aging 15: 399-408, 1994[Web of Science][Medline].

43.   Sawyer, DB, Siwik DA, Xiao L, Pimentel DR, Singh K, and Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 34: 379-388, 2002[Web of Science][Medline].

44.   Singal, PK, Dhalla AK, Hill M, and Thomas TP. Endogenous antioxidant changes in the myocardium in response to acute and chronic stress conditions. Mol Cell Biochem 129: 179-186, 1993[Web of Science][Medline].

45.   Sohal, RS. The free radical hypothesis of aging: an appraisal of the current status. Aging (Milano) 5: 3-17, 1993[Medline].

46.   Stadtman, ER. Protein oxidation in aging and age-related diseases. Ann NY Acad Sci 928: 22-38, 2001[Web of Science][Medline].

47.   Strolin Benedetti, M, and Dostert P. Monoamine oxidase, brain ageing and degenerative diseases. Biochem Pharmacol 38: 555-561, 1989[Web of Science][Medline].

48.   Tate, CA, Helgason T, Hyek MF, McBride RP, Chen M, Richardson MA, and Taffet GE. SERCA2a and mitochondrial cytochrome oxidase expression are increased in hearts of exercise-trained old rats. Am J Physiol Heart Circ Physiol 271: H68-H72, 1996[Abstract/Free Full Text].

49.   Tiago Guimaraes, J, and Soares-da-Silva P. Unusual pattern of beta-phenylethylamine deamination in the rat heart. Neurobiology (Bp) 8: 109-118, 2000.

50.   Tokoro, T, Ito H, and Suzuki T. Alterations in mitochondrial DNA and enzyme activities in hypertrophied myocardium of stroke-prone SHRS. Clin Exp Hypertens 18: 595-606, 1996[Web of Science][Medline].

51.   Tolmasoff, JM, Ono T, and Cutler RG. Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species. Proc Natl Acad Sci USA 77: 2777-2781, 1980[Abstract/Free Full Text].

52.   Vindis, C, Seguelas MH, Bianchi P, Parini A, and Cambon C. Monoamine oxidase B induces ERK-dependent cell mitogenesis by hydrogen peroxide generation. Biochem Biophys Res Commun 271: 181-185, 2000[Web of Science][Medline].

53.   Vindis, C, Seguelas MH, Lanier S, Parini A, and Cambon C. Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase. Kidney Int 59: 76-86, 2001[Web of Science][Medline].

54.   Von Wangenheim, KH, and Peterson HP. Control of cell proliferation by progress in differentiation: clues to mechanisms of aging, cancer causation and therapy. J Theor Biol 193: 663-678, 1998[Web of Science][Medline].

55.   Warner, HR. Aging and regulation of apoptosis. Curr Top Cell Regul 35: 107-121, 1997[Web of Science][Medline].

56.   Weyler, W, Hsu YP, and Breakefield XO. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 47: 391-417, 1990[Web of Science][Medline].

57.   Wickens, AP. Ageing and the free radical theory. Respir Physiol 128: 379-391, 2001[Web of Science][Medline].

Am J Physiol Heart Circ Physiol 284(4):H1460-H1467
0363-6135/03 $5.00 Copyright © 2003 the American Physiological Society


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. A. Pena-Silva, J. D. Miller, Y. Chu, and D. D. Heistad
Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1354 - H1360.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. Villeneuve, A. Caudrillier, C. Ordener, N. Pizzinat, A. Parini, and J. Mialet-Perez
Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H821 - H828.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. Boengler, R. Schulz, and G. Heusch
Loss of cardioprotection with ageing
Cardiovasc Res, July 15, 2009; 83(2): 247 - 261.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. N. Kavazis, S. Alvarez, E. Talbert, Y. Lee, and S. K. Powers
Exercise training induces a cardioprotective phenotype and alterations in cardiac subsarcolemmal and intermyofibrillar mitochondrial proteins
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H144 - H152.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
L.-H. Xie, F. Chen, H. S. Karagueuzian, and J. N. Weiss
Oxidative Stress-Induced Afterdepolarizations and Calmodulin Kinase II Signaling
Circ. Res., January 2, 2009; 104(1): 79 - 86.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
D. Pchejetski, O. Kunduzova, A. Dayon, D. Calise, M.-H. Seguelas, N. Leducq, I. Seif, A. Parini, and O. Cuvillier
Oxidative Stress-Dependent Sphingosine Kinase-1 Inhibition Mediates Monoamine Oxidase A-Associated Cardiac Cell Apoptosis
Circ. Res., January 5, 2007; 100(1): 41 - 49.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
P. Bianchi, O. Kunduzova, E. Masini, C. Cambon, D. Bani, L. Raimondi, M.-H. Seguelas, S. Nistri, W. Colucci, N. Leducq, et al.
Oxidative Stress by Monoamine Oxidase Mediates Receptor-Independent Cardiomyocyte Apoptosis by Serotonin and Postischemic Myocardial Injury
Circulation, November 22, 2005; 112(21): 3297 - 3305.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/4/H1460    most recent
00700.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maurel, A.
Right arrow Articles by Francés, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maurel, A.
Right arrow Articles by Francés, B.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online